<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Emergency Health Care</title>
<title_fa></title_fa>
<short_title>J Emerg Health Care</short_title>
<subject>Medical Sciences</subject>
<web_url>http://intjmi.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>3092-6319</journal_id_issn>
<journal_id_issn_online>3092-6319</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Assessment the clinical and paraclinical effects of enhanced external counter pulsation therapy in patients with coronary artery disease</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Background: the aim of this study was assessment the clinical and paraclinical effects of enhanced external counter pulsation (EECP) therapy in patients with coronary artery disease. Patients and Methods: We performed a retrospective analysis of data related to all patients who received EECP treatment at Shafa hospitals in Sari, Iran from 21 March 2013 to 21 March 2015. All patient&amp;rsquo;s data included demographic data, history of underlying disease, clinical sign and symptom, laboratory data (hemoglobin, triglyceride (TG), cholesterol, Low-density lipoprotein (LDL), High-density lipoprotein (HDL)) and left ventricular ejection fraction (LVEF) in before and after treatment by EECP were collected. Results: the data of 48 patients (include 25 men) with mean age of 62.20&amp;plusmn;10.15 years were collected. The mean of TG, Cholesterol, LDL and HDL were not significantly change after EECP therapy. However, the mean of hemoglobin (10.47&amp;plusmn;0.81mg/dl vs. 10.20&amp;plusmn;1.03mg/dl, P=0.019) and LVEF (40.10&amp;plusmn;5.40% vs. 36.04&amp;plusmn;5.64%, P&lt;0.0001) were significantly increased after EECP therapy. Also, the mean of systolic (112.81&amp;plusmn;6.75mmHg vs. 124.27&amp;plusmn;9.56mmHg, P&lt;0.0001) and diastolic (71.35&amp;plusmn;5.90mmHg vs. 75.52&amp;plusmn;5.38mmHg, P&lt;0.0001) blood pressure were significantly decrease after treatment with EECP. Clinical improvement of chest pain, muscle weakness, dyspnea and daily activity were observed in 14 patients (29.2%), 11 patients (22.9%), 24 patients (50%) and 28 patients (58.3%), respectively. Finally 31 patients (64.6%) were satisfy form this treatment. The complication included low back pain in 6 patients (12.5%) and paresthesia in 4 patients (8.3%). Conclusion: In conclusion, the results of our study show EECP therapy is a safe treatment and can reduced systolic and diastolic blood pressure, increase hemoglobin level and LVEF and improve clinical condition of CAD patients.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>coronary artery disease, enhanced external counter pulsation, left ventricular ejection fraction, clinical parameters, paraclinical parameters</keyword>
	<start_page>245</start_page>
	<end_page>248</end_page>
	<web_url>http://intjmi.com/browse.php?a_code=A-10-1-86&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Shervin</first_name>
	<middle_name></middle_name>
	<last_name>ziabakhsh Tabary</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002458</code>
	<orcid>10031947532846002458</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Cardiac surgery department, Fatemeh Zahra hospital of Sari, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Keyvan</first_name>
	<middle_name></middle_name>
	<last_name>Yousefnejad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002459</code>
	<orcid>10031947532846002459</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cardiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Taraneh</first_name>
	<middle_name></middle_name>
	<last_name>Ziaee</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002460</code>
	<orcid>10031947532846002460</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Medicine, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mehran</first_name>
	<middle_name></middle_name>
	<last_name>Fazli</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846002461</code>
	<orcid>10031947532846002461</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>General Practitioner in Imam Khomeini Hospital of Esfarayen, Esfarayen Faculty of Medical Sciences, Esfarayen, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
